Safotibant
Safotibant (LF-22-0542) is a selective bradykinin B1 receptor antagonist developed for research into diabetic macular edema. It exhibits anti-inflammatory and analgesic properties, with studies demonstrating its activity in both in vitro receptor binding assays and in vivo models of ocular inflammation and diabetic retinopathy.
Product Specifications
CAS Number
633698-99-4
Product Name Alternative
Bradykinin Receptor, bradykinin B1, BradykininReceptor, LF220542, LF-220542, LF-22-0542, LF22-0542, LF 220542, LF 22-0542, Safotibant
Field of Research
Pharmacology & Drug Discovery
Purity
98.93% (May vary between batches)
Solubility
DMSO:50 mg/mL (99.48 mM)
Smiles
S (N (CCOCC (N (CC1=CC=C (C=C1) C=2NCCN2) C) =O) C) (=O) (=O) C3=C (C) C=C (OC) C=C3C
Molecular Formula
C25H34N4O5S
Molecular Weight
502.63
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
353668-01 48 Tests
ACTH (Corticotropin Releasing Hormone) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 353668-02 96 Tests
ACTH (Corticotropin Releasing Hormone) BioAssayTM ELISA Kit (Rat) discontinued
Sign In for Pricing
View Details 23749061 1.0 µg DNA
HNRNPK Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details